Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5447939A · kind A · utility
44Cited by
5References
39Claims
0Family size
Inventors
Key dates
| Filing date | Jul 25, 1994 |
| Grant date | Sep 5, 1995 |
| Priority date | — |
| Expiry date | Jul 25, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/708
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods directed generally to the control of neural activity and to the treatment of neural disorders. More particularly, the present invention is directed to methods for the modification of mammalian neural activity through the administration of carbon monoxide dependent guanylyl cyclase modulating purine derivatives. The methods of the present invention may be used to affect a variety of neurological activities and to therapeutically or prophylactically treat a wide variety of neurodegenerative and neurological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.